Home

Mead Johnson Nutrition

Up 80%, It's Time to Sell

Wed, 11/18/2009 - 14:14 by Brian Orelli

After seeing shares of its spinoff Mead Johnson Nutrition (NYSE: MJN) nearly double since its IPO in February, Bristol-Myers Squibb (NYSE: BMY) has decided now's the time to sell the 83% of the baby formula producer that it still owns.